Alimta 500 mg (Pemetrexed)
| Product Name | : Alimta |
| Generic Name | : Pemetrexed |
| Formulation | : Injection |
| Available Pack Size | : 10’s |
| Available Strengths | : 500 mg |
| Registrations | : Export Only |
Request A Call Back
Product Description
emetrexed is indicated for:
- Initial treatment of patients with locally advanced or metastatic, non-squamous, non-small cell lung cancer (NSCLC) in combination with cisplatin.
- Maintenance treatment of patients with locally advanced or metastatic, non-squamous NSCLC whose disease has not progressed after four cycles of platinum-based first-line chemotherapy, as a single agent.
- Treatment of patients with recurrent, metastatic non-squamous, NSCLC after prior chemotherapy, as a single agent.
